Lewis T. Williams - Insider Trading & Ownership

Location
C/O Five Prime Therapeutics, Inc., Two Corporate Drive, South San Francisco, CA
Summary
The estimated net worth of Lewis T. Williams is at least $116M dollars as of January 6, 2025. Lewis T. Williams is the Director of Arcellx, Inc. and owns shares of Arcellx, Inc. (ACLX) stock worth about $116M. Lewis T. Williams is the Director of Protagonist Therapeutics, Inc and owns shares of Protagonist Therapeutics, Inc (PTGX) stock worth about $230K.
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Lewis T. "Rusty" Williams
All Insider Reports
All Insider Reports

Ownership of Lewis T. Williams

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ACLX Arcellx, Inc. Director $116M Feb 8, 2022
PTGX Protagonist Therapeutics, Inc Director $230K Jan 2, 2025
NGNE Neurogene Inc. Director May 11, 2021

Insider Transactions Reported by Lewis T. Williams:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.